[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[S. 3713 Introduced in Senate (IS)]

<DOC>






118th CONGRESS
  2d Session
                                S. 3713

To prohibit the Federal Government from conducting, funding, approving, 
or otherwise supporting any research involving human fetal tissue that 
   is obtained pursuant to an induced abortion, and to prohibit the 
   solicitation or knowing acquisition, receipt, or acceptance of a 
                        donation of such tissue.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                            January 31, 2024

 Mrs. Hyde-Smith (for herself, Mr. Braun, Mr. Mullin, Mr. Cotton, Mr. 
  Thune, Mr. Daines, Mr. Lee, Mr. Risch, Mr. Rubio, Mr. Lankford, Mr. 
  Cramer, Mrs. Blackburn, Mr. Budd, Mr. Rounds, Mrs. Fischer, and Mr. 
   Kennedy) introduced the following bill; which was read twice and 
  referred to the Committee on Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
To prohibit the Federal Government from conducting, funding, approving, 
or otherwise supporting any research involving human fetal tissue that 
   is obtained pursuant to an induced abortion, and to prohibit the 
   solicitation or knowing acquisition, receipt, or acceptance of a 
                        donation of such tissue.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Protecting Life and Integrity in 
Research Act of 2024''.

SEC. 2. NO RESEARCH INVOLVING HUMAN FETAL TISSUE OBTAINED PURSUANT TO 
              AN INDUCED ABORTION.

    (a) In General.--
            (1) In general.--No Federal department, agency, or office 
        may conduct, fund, approve, or otherwise support any research 
        involving human fetal tissue that is obtained pursuant to an 
        induced abortion.
            (2) Development of new, ethical cell lines.--Subsection (a) 
        does not limit the authority of the head of any Federal 
        department, agency, or office, to develop or support the 
        development of new, high-efficiency cell lines, including for 
        the production of vaccines and genetic vectors, so long as the 
        cell lines are not derived from human fetal tissue that is 
        obtained pursuant to an induced abortion.
            (3) Research involving human fetal tissue obtained after a 
        miscarriage or stillbirth permitted.--Any research of any 
        Federal department, agency, or office on human fetal tissue 
        obtained after a miscarriage or stillbirth shall be conducted 
        or supported in accordance with section 498A of the Public 
        Health Service Act (42 U.S.C. 289g-1).
            (4) Definition.--In this subsection, the term ``human fetal 
        tissue'' has the meaning given such term in section 498A(g) of 
        the Public Health Service Act (42 U.S.C. 289g-1(g)).
    (b) Amendments to the PHSA Limiting Human Fetal Tissue Research to 
Tissue Obtained After a Miscarriage or Stillbirth.--Section 498A of the 
Public Health Service Act (42 U.S.C. 289g-1) is amended--
            (1) in the section heading, by striking ``transplantation 
        of fetal tissue'' and inserting ``human fetal tissue obtained 
        after a miscarriage or stillbirth'';
            (2) by amending subsection (a) to read as follows:
    ``(a) Establishment of Program.--The Secretary may conduct or 
support research on human fetal tissue obtained after a miscarriage or 
a stillbirth.'';
            (3) in subsection (b)--
                    (A) in paragraph (1)(B), by inserting ``if the 
                human fetal tissue is intended for transplantation,'' 
                before ``the donation''; and
                    (B) in paragraph (2)--
                            (i) by striking subparagraph (A); and
                            (ii) by redesignating subparagraphs (B) and 
                        (C) as subparagraphs (A) and (B), respectively;
            (4) in subsection (c)(1)(B), by striking ``pursuant to a 
        spontaneous or induced abortion or pursuant to'' and inserting 
        ``after a miscarriage or''; and
            (5) by amending subsection (g) to read as follows:
    ``(g) Definitions.--In this section:
            ``(1) Human fetal tissue.--The term `human fetal tissue' 
        means tissue or cells obtained from a dead unborn child 
        pursuant to an induced abortion, a miscarriage, or a 
        stillbirth.
            ``(2) Miscarriage.--The term `miscarriage' means the 
        involuntary death of an unborn child who was carried in the 
        womb for a period of less than 20 weeks.
            ``(3) Stillbirth.--The term `stillbirth' means the 
        involuntary death of an unborn child who was carried in the 
        womb for a period of 20 weeks or more.
            ``(4) Unborn child.---The term `unborn child' has the 
        meaning given such term in section 1841(d) of title 18, United 
        States Code.''.
    (c) Conforming Repeal.--Section 113 of the National Institutes of 
Health Revitalization Act of 1993 (42 U.S.C. 289g-1 note) is repealed.

SEC. 3. PROHIBITION AGAINST SOLICITATION OR KNOWING ACQUISITION, 
              RECEIPT, OR ACCEPTANCE OF A DONATION OF HUMAN FETAL 
              TISSUE KNOWING THAT THE TISSUE WAS OBTAINED PURSUANT TO 
              AN INDUCED ABORTION.

    (a) In General.--Paragraph (1) of section 498B(c) of the Public 
Health Service Act (42 U.S.C. 289g-2(c)) is amended to read as follows:
            ``(1) solicit or knowingly acquire, receive, or accept a 
        donation (excluding any transfer for purposes of autopsy or 
        burial) of human fetal tissue knowing that--
                    ``(A) a human pregnancy was deliberately initiated 
                to provide such tissue; or
                    ``(B) the tissue was obtained pursuant to an 
                induced abortion; or''.
    (b) Conforming Changes.--Section 498B of the Public Health Service 
Act (42 U.S.C. 289g-2) is amended--
            (1) by striking subsection (b);
            (2) by redesignating subsections (c) through (e) as 
        subsections (b) through (d), respectively; and
            (3) in subsection (c), as redesignated--
                    (A) in paragraph (1), by striking ``(a), (b), or 
                (c)'' and inserting ``(a) or (b)''; and
                    (B) in paragraph (2), by striking ``or (b)(3)''.
                                 <all>